Lee's Pharmaceutical Holdings Limited Appoints Sun Yuanjue as Chief Medical Officer
September 01, 2021 at 06:20 am EDT
The Board of Lee's Pharmaceutical Holdings Limited announced the appointment of Mr. Sun Yuanjue ('Mr. Sun') as the Chief Medical Officer of the Group with effect from 1 September 2021. Before joining the Group, Mr. Sun served as the Chief Physician of Medical Oncology at Shanghai Fengxian District Central Hospital since 2016, and he also served as the President of Shanghai Fengxian District Guhua Hospital during the period from July 2020 to June 2021. As the Chief Medical Officer of the Group, Mr. Sun will be responsible for formulating medical strategies and product development for the Group's product introductions, formulating product development strategies, facilitating and accelerating product commercialisation process, and taking charge of medical affairs, drug registrations and compliance matters for pipeline products.